![]() Cajal Neuroscience Cajal Neuroscience is a drug discovery company focused on neurodegenerative diseases. | ![]() FibroGen FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs. | Cerba Research Cerba Research is a provider of research and development services for the pharmaceutical and medical device sectors. | ![]() Molecular Templates Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer. | |
Founding Date | Founding Date 2020 | Founding Date 1993 | Founding Date 2018 | Founding Date 2009 |
Type | Type Private | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Seattle, US HQ | Locations San Francisco, US HQ | Locations Gent, BE HQ Kogarah, AU Montpellier, FR Saint Ouen L'aumône, FR Shinjuku City, JP Johannesburg, ZA see more | Locations Austin, US HQ New York, US |
Employees | Employees 39 | Employees 53115% increase | Employees 619 | Employees 6272% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 30.7 m | Valuation ($) N/A | Valuation ($) 3.3 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $6.4m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $57.3m (FY, 2023) |
Net income | Net income N/A | Net income $183.5m (FY, 2025) | Net income N/A | Net income ($8.1m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised $ 96m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 89.6m |

FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
View companyCerba Research is a provider of research and development services for the pharmaceutical and medical device sectors.
View company
Molecular Templates (MTEM) is a biopharmaceutical company focused on the discovery and development of differentiated, targeted, biologic therapeutics for cancer.
View company